Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: Update 2009

Supportive Care in Cancer

Volumn 19, Issue SUPPL. 1, 2011, Pages

  Feyer, Petra Christine ^e   Maranzano, Ernesto ^a   Molassiotis, Alexander ^b   Roila, Fausto ^a   Clark Snow, Rebecca A ^c   Jordan, Karin ^d  

^a S MARIA HOSPITAL   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e University of Halle ^*

Author keywords

5 HT3 receptor antagonists; Guidelines; Radiotherapy induced nausea and vomiting; Risk factors

Indexed keywords

ANTIEMETIC AGENT; CHLORPROMAZINE; CORTICOSTEROID; DEXAMETHASONE; DOLASETRON MESILATE; GRANISETRON; LEVONANTRADOL; LORAZEPAM; METOCLOPRAMIDE; NABILONE; ONDANSETRON; PALONOSETRON; PHENOTHIAZINE; PLACEBO; PROCHLORPERAZINE; SEROTONIN 3 ANTAGONIST; TETRAHYDROCANNABINOL; TROPISETRON;

ABDOMINAL RADIOTHERAPY; ASTHENIA; CANCER RADIOTHERAPY; CONSTIPATION; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DRUG DOSE ESCALATION; DRUG INDUCED HEADACHE; HUMAN; INCIDENCE; LOW DRUG DOSE; NAUSEA AND VOMITING; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOTHERAPY INDUCED NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; TREATMENT DURATION; WHOLE BODY RADIATION;

ANTIEMETICS; GLUCOCORTICOIDS; HUMANS; NAUSEA; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY; RECEPTORS, NEUROKININ-1; RISK FACTORS; SEROTONIN ANTAGONISTS; VOMITING;

EID: 79953300071     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-010-0950-6     Document Type: Review

References (47)

1. Aass N, Hatun DE, Thoresen M, Fossa SD (1997) Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients. Radiother Oncol 45:125-128 (Pubitemid 27521083)
2. Belli C, Dahl T, Herrstedt J (2008) Palonosetron plus prednisolone in patients receiving fractionated radiotherapy plus weekly cisplatin. Support Care Cancer 16:01-004
3. Bey P, Wilkinson PM, Resbeut M, Bourdin S, Le Floch O, Hahne W et al (1996) A double-blind, placebo-controlled trial of I.V. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients. Support Care Cancer 4:378-383 (Pubitemid 126473712)
4. Dimitrijevic J, Medic-Milijic N (2009) Prevention of nausea and vomiting induced by chemotherapy followed by combined chemo/ radiotherapy in head and neck cancer patients. Support Care Cancer 17:# 02-009
5. Enblom A, Bergius Axelsson B, Steineck G, Hammar M, Borjeson S (2009) One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. Support Care Cancer 17:23-32
6. Feyer P (2004) The importance of simple, easy-to-follow antiemetic guidelines. Acta Oncol 43 Suppl 15:5-8
7. Feyer P, Maranzano E, Molassiotis A, Clark-Snow RA, Roila F, Warr D et al (2005) Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines. Support Care Cancer 13:122-128 (Pubitemid 40558169)
8. Feyer P, Seegenschmiedt MH (2003) Antiemetic patterns of care for radiotherapy induced nausea and vomiting. ECCO 12:929
9. Feyer P, Seegenschmiedt MH, Steingraeber M (2005) Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies. Support Care Cancer 13:671-678 (Pubitemid 41435557)
10. Feyer PC, Stewart AL, Titlbach OJ (1998) Aetiology and prevention of emesis induced by radiotherapy. Support Care Cancer 6:253-260 (Pubitemid 28213062)
11. Feyer P, Zimmermann JS, Titlbach OJ, Buchali A, Hinkelbein M, Budach V (1998) Radiotherapy-induced emesis. An overview. Strahlenther Onkol 174 Suppl 3:56-61
12. Franzen L, Nyman J, Hagberg H, Jakobsson M, Sorbe B, Nyth AL et al (1996) A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy. Ann Oncol 7:587-592 (Pubitemid 26285638)
13. Goodin S, Cunningham R (2002) 5-Ht(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their sideeffect profile. Oncologist 7:424-436 (Pubitemid 35266135)
14. Horiot JC (2004) Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting? Int J Radiat Oncol Biol Phys 60:1018-1025
15. Huang X, Guo N, Fan Y (1995) Ondansetron in the prophylaxis of acute emesis induced by supra-high single dose total body irradiation (TBI). Zhonghua Zhong Liu Za Zhi 17:64-66
16. Italian Group for Antiemetic Research (1992) Ondansetron+ dexamethasone vs metoclopramide+dexamethasone+diphenhydramine in prevention of cisplatin-induced emesis. Lancet 340:96-99
17. Jordan K, Kinitz I, Voigt W, Behlendorf T, Wolf HH, Schmoll HJ (2009) Safety and efficacy of a triple antiemetic combination with the Nk-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy. Eur J Cancer 45:1184-1187
18. Jordan K, Schmoll HJ, Aapro MS (2007) Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 61:162-175 (Pubitemid 46073781)
19. Khoo VS, Rainford K, Horwich A, Dearnaley DP (1997) The effect of antiemetics and reduced radiation fields on acute gastrointestinal morbidity of adjuvant radiotherapy in stage I seminoma of the testis: a randomized pilot study. Clin Oncol (R Coll Radiol) 9:252-257 (Pubitemid 27450102)
20. Kirkbride P, Bezjak A, Pater J, Zee B, Palmer MJ, Wong R et al (2000) Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group Phase III Study. J Clin Oncol 18:1960-1966 (Pubitemid 30261935)
21. Krengli M, Lazzari R, Manara M (1996) The use of granisetron per os in radiotherapy-induced emesis. Minerva Med 87:605-608 (Pubitemid 27077216)
22. Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM et al (2006) American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006. J Clin Oncol 24:2932-2947 (Pubitemid 46630595)
23. Lanciano R, Sherman DM, Michalski J, Preston AJ, Yocom K, Friedman C (2001) The efficacy and safety of once-daily kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy. Cancer Investig 19:763-772 (Pubitemid 33151205)
24. Lebourgeois JP, Mckenna CJ, Coster B, Feyer P, Franzen L, Goedhals L et al (1999) Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-Ht(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment. Clin Oncol (R Coll Radiol) 11:340-347
25. Lucraft HH, Palmer MK (1982) Randomised clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting. Clin Radiol 33:621-622 (Pubitemid 13250784)
26. Maisano R, Pergolizzi S, Settineri N (1998) Escalating dose of oral ondansetron in the prevention of radiation induced emesis. Anticancer Res 18:2011-2013 (Pubitemid 28344863)
27. Maranzano E (2001) Radiation-induced emesis: a problem with many open questions. Tumori 87:213-218
28. Maranzano E, Bellavita R, De Angelis V (2004) Double-blind randomized clinical trial comparing prophylaxis vs. rescue treatment in patients undergoing fractionated upper abdomen radiotherapy. Radiother Oncol 73(Suppl 1):S388
29. Maranzano E, De Angelis V, Pergolizzi S, Constantini S, Lupattelli M, Frata P et al. (2009) Radiation-induced emesis (RIE): results of the Second Observational Multicenter Italian Trial. Radiother Oncol (in press)
30. Maranzano E, Feyer P, Molassiotis A, Rossi R, Clark-Snow RA, Olver I et al (2005) Evidence-based recommendations for the use of antiemetics in radiotherapy. Radiother Oncol 76:227-233 (Pubitemid 41394271)
31. Miralbell R, Coucke P, Behrouz F, Blazek N, Melliger M, Philipp S et al (1995) Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for nonresponders to metoclopramide. Eur J Cancer 31A:1461-1464
32. Mystakidou K, Katsouda E, Linou A, Parpa E, Kouloulias V, Nikolaou V et al (2006) Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas: a prospective randomized open label study in cancer patients. Med Oncol 23:251-262 (Pubitemid 43780309)
33. NCCN (2009) National Comprehensive Cancer Network: Antiemesis, Clinical Practice Guidelines in Oncology-V.1.
34. Prentice HG, Cunningham S, Gandhi L, Cunningham J, Collis C, Hamon MD (1995) Granisetron in the prevention of irradiation-induced emesis. Bone Marrow Transplant 15:445-448
35. Priestman SG, Priestman TJ, Canney PA (1987) A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea. Clin Radiol 38:543-544 (Pubitemid 17142354)
36. Priestman TJ, Roberts JT, Lucraft H, Collis CH, Adams M, Upadhyaya BK et al (1990) Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation. Clin Oncol (R Coll Radiol) 2:71-75
37. Priestman TJ, Roberts JT, Upadhyaya BK (1993) A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy. Clin Oncol (R Coll Radiol) 5:358-363 (Pubitemid 24005058)
38. Roberts JT (1992) Ondansetron in the control of refractory emesis following radiotherapy. Clin Oncol (R Coll Radiol) 4:67-68
39. Spitzer TR, Bryson JC, Cirenza E, Foelber R, Wallerstadt M, Stout C et al (1994) Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation. J Clin Oncol 12:2432-2438
40. Spitzer TR, Friedman CJ, Bushnell W, Frankel SR, Raschko J (2000) Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyper-fractionated total body irradiation. Bone Marrow Transplant 26:203-210 (Pubitemid 30496968)
41. Sykes AJ, Kiltie AE, Stewart AL (1997) Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy. Support Care Cancer 5:500-503 (Pubitemid 27494877)
42. The Italian Group for Antiemetic Research in Radiotherapy (1999) Radiation-induced emesis: a prospective observational multicenter Italian trial. Int J Radiat Oncol Biol Phys 44:619-625
43. Tiley C, Powles R, Catalano J, Treleaven J, Eshelby J, Hewetson M et al (1992) Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation. Leuk Lymphoma 7:317-321
44. Ungerleider JT, Andrysiak TA, Fairbanks LA, Tesler AS, Parker RG (1984) Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy. Radiology 150:598-599
45. Urba S (2007) Radiation-induced nausea and vomiting. J Natl Compr Canc Netw 5:60-65
46. Wong RK, Paul N, Ding K, Whitehead M, Brundage M, Fyles A et al (2006) 5-Hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (Sc19). J Clin Oncol 24:3458-3464 (Pubitemid 46638904)
47. Yamamoto K, Nohara K, Furuya T, Yamatodani A (2005) Ondansetron, dexamethasone and an Nk1 antagonist block radiation sickness in mice. Pharmacol Biochem Behav 82:24-29 (Pubitemid 41423483)